K U 725 (Hydrochlorothiazide and moexipril hydrochloride 25 mg / 15 mg)
Pill imprint K U 725 has been identified as Hydrochlorothiazide and moexipril hydrochloride 25 mg / 15 mg.
Hydrochlorothiazide/moexipril is used in the treatment of high blood pressure and belongs to the drug class antihypertensive combinations. There is positive evidence of human fetal risk during pregnancy. Hydrochlorothiazide/moexipril 25 mg / 15 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for K U 725
- 25 mg / 15 mg
- 14.00 mm
- Figure eight-shape
- Prescription only
- Drug Class:
- Antihypertensive combinations
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Cobalt Laboratories Inc
- National Drug Code (NDC):
- Inactive Ingredients:
polyethylene glycol 6000
ferric oxide red
More about hydrochlorothiazide/moexipril
- Hydrochlorothiazide and moexipril
- Moexipril and hydrochlorothiazide (Advanced Reading)
- Other brands: Uniretic
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.